Connection

Co-Authors

This is a "connection" page, showing publications co-authored by LAURA PETERSEN and LECHAUNCY WOODARD.
Connection Strength

5.486
  1. Impact of a Pay-for-Performance Program on Care for Black Patients with Hypertension: Important Answers in the Era of the Affordable Care Act. Health Serv Res. 2017 06; 52(3):1138-1155.
    View in: PubMed
    Score: 0.565
  2. Effects of individual physician-level and practice-level financial incentives on hypertension care: a randomized trial. JAMA. 2013 Sep 11; 310(10):1042-50.
    View in: PubMed
    Score: 0.466
  3. Impact of clinical complexity on the quality of diabetes care. Am J Manag Care. 2012 09; 18(9):508-14.
    View in: PubMed
    Score: 0.434
  4. Treating chronically ill people with diabetes mellitus with limited life expectancy: implications for performance measurement. J Am Geriatr Soc. 2012 Feb; 60(2):193-201.
    View in: PubMed
    Score: 0.416
  5. Design, rationale, and baseline characteristics of a cluster randomized controlled trial of pay for performance for hypertension treatment: study protocol. Implement Sci. 2011 Oct 03; 6:114.
    View in: PubMed
    Score: 0.407
  6. Impact of comorbidity type on measures of quality for diabetes care. Med Care. 2011 Jun; 49(6):605-10.
    View in: PubMed
    Score: 0.398
  7. Improving the performance of performance measurement. J Gen Intern Med. 2010 Feb; 25(2):100-1.
    View in: PubMed
    Score: 0.363
  8. Racial differences in attitudes regarding cardiovascular disease prevention and treatment: a qualitative study. Patient Educ Couns. 2005 May; 57(2):225-31.
    View in: PubMed
    Score: 0.261
  9. Is lipid-lowering therapy underused by African Americans at high risk of coronary heart disease within the VA health care system? Am J Public Health. 2004 Dec; 94(12):2112-7.
    View in: PubMed
    Score: 0.254
  10. Impact of Patient-Centered Medical Home Implementation on Diabetes Control in the Veterans Health Administration. J Gen Intern Med. 2018 08; 33(8):1276-1282.
    View in: PubMed
    Score: 0.160
  11. Calculations of Financial Incentives for Providers in a Pay-for-Performance Program: Manual Review Versus Data From Structured Fields in Electronic Health Records. Med Care. 2015 Oct; 53(10):901-7.
    View in: PubMed
    Score: 0.134
  12. Publishing protocols for partnered research. J Gen Intern Med. 2014 Dec; 29 Suppl 4:820-4.
    View in: PubMed
    Score: 0.127
  13. Is high-intensity statin therapy associated with lower statin adherence compared with low- to moderate-intensity statin therapy? Implications of the 2013 American College of Cardiology/American Heart Association Cholesterol Management Guidelines. Clin Cardiol. 2014 Nov; 37(11):653-9.
    View in: PubMed
    Score: 0.126
  14. Gender disparities in evidence-based statin therapy in patients with cardiovascular disease. Am J Cardiol. 2015 Jan 01; 115(1):21-6.
    View in: PubMed
    Score: 0.126
  15. Financial incentives to control hypertension in patients--reply. JAMA. 2014 Jan 15; 311(3):303-4.
    View in: PubMed
    Score: 0.119
  16. Correlates of repeat lipid testing in patients with coronary heart disease. JAMA Intern Med. 2013 Aug 12; 173(15):1439-44.
    View in: PubMed
    Score: 0.116
  17. Variations in definitions of mortality have little influence on neonatal intensive care unit performance ratings. J Pediatr. 2013 Jan; 162(1):50-5.e2.
    View in: PubMed
    Score: 0.108
  18. Non-high-density lipoprotein cholesterol reporting and goal attainment in primary care. J Clin Lipidol. 2012 Nov-Dec; 6(6):545-52.
    View in: PubMed
    Score: 0.106
  19. Frequency and correlates of treatment intensification for elevated cholesterol levels in patients with cardiovascular disease. Am Heart J. 2011 Oct; 162(4):725-732.e1.
    View in: PubMed
    Score: 0.101
  20. Institutional, provider, and patient correlates of low-density lipoprotein and non-high-density lipoprotein cholesterol goal attainment according to the Adult Treatment Panel III guidelines. Am Heart J. 2011 Jun; 161(6):1140-6.
    View in: PubMed
    Score: 0.099
  21. Improving benchmarking by using an explicit framework for the development of composite indicators: an example using pediatric quality of care. Implement Sci. 2010 Feb 09; 5:13.
    View in: PubMed
    Score: 0.091
  22. Will hypertension performance measures used for pay-for-performance programs penalize those who care for medically complex patients? Circulation. 2009 Jun 16; 119(23):2978-85.
    View in: PubMed
    Score: 0.087
  23. Health care funding levels and patient outcomes: a national study. Health Econ. 2007 Apr; 16(4):385-93.
    View in: PubMed
    Score: 0.074
  24. Does pay-for-performance improve the quality of health care? Ann Intern Med. 2006 Aug 15; 145(4):265-72.
    View in: PubMed
    Score: 0.071
  25. Comparison of the predictive validity of diagnosis-based risk adjusters for clinical outcomes. Med Care. 2005 Jan; 43(1):61-7.
    View in: PubMed
    Score: 0.064
  26. Use of smoking cessation interventions and aspirin for secondary prevention: are there racial disparities? Am J Med Qual. 2004 Jul-Aug; 19(4):166-71.
    View in: PubMed
    Score: 0.062
  27. An evidence-based, structured, expert approach to selecting essential indicators of primary care quality. PLoS One. 2022; 17(1):e0261263.
    View in: PubMed
    Score: 0.052
  28. Impact of team configuration and team stability on primary care quality. Implement Sci. 2019 03 06; 14(1):22.
    View in: PubMed
    Score: 0.043
  29. Statin Use and Its Facility-Level Variation in Patients With Diabetes: Insight From the Veterans Affairs National Database. Clin Cardiol. 2016 Apr; 39(4):185-91.
    View in: PubMed
    Score: 0.035
  30. Barriers to non-HDL cholesterol goal attainment by providers. Am J Med. 2011 Sep; 124(9):876-80.e2.
    View in: PubMed
    Score: 0.025
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.